• Small Nuclear Ribonucleoprotein Polypeptide N and Ubiquitin Protein Ligase E3A (SNRPN/UBE3A) Methylation Analysis
  • Mercury, 24 Hour, Urine
  • Albumin Creatinine Ratio
  • Vitamin B6 (Pyridoxal Phosphate)
  • 17-Hydroxyprogesterone, Serum
  • PHOX2B gene mutation analysis
  • Yeast (Fungal) Infections
  • Fungitell® ß-D Glucan, CSF
  • Chromosome Breakage Study, Tissue
  • Hepatitis C Virus (HCV) Antibody
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Breast Cancer Antigen CA 15-3
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Breast Cancer Antigen CA 15-3
Medical Test

Interpretation
Access to Breast Cancer Antigen CA 15-3 is restricted.